Alberto C. Munari-Frati
Mexico, MEX, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier.
Journal: Therapeutics and clinical risk management
Published: July 05, 2023
Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy.
Journal: Revista de gastroenterologia de Mexico (English)
Published: June 24, 2019
Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico.
Journal: Revista de gastroenterologia de Mexico (English)
Published: December 17, 2017
Chronic venous disease treated with sulodexide: a survey among primary care physicians in Mexico.
Journal: International angiology : a journal of the International Union of Angiology
Published: November 25, 2017
Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast Mexico.
Journal: Revista de gastroenterologia de Mexico
Published: June 27, 2016
Susceptibility of bacteria isolated from acute gastrointestinal infections to rifaximin and other antimicrobial agents in Mexico.
Journal: Revista de gastroenterologia de Mexico
Published: April 23, 2015
Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and in diabetic complications
Journal: Archivos de cardiologia de Mexico
Published: June 27, 2013
Medical significance of endothelial glycocalyx
Journal: Archivos de cardiologia de Mexico
Published: October 11, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026